Stocks Hitting 52-Week Lows

shares reached a new 52-week low of $3.94 after the company reported successful completion of a planned interim analysis of its STOP-HE study, a double-blind placebo-controlled study of OCR-002 in patients with acute hepatic encephalopathy.

shares fell 3.05% to touch a new 52-week low of $32.45 after dropping 3.21% on Wednesday.

shares touched a new 52-week low of $2.45. Taomee Holdings' PEG ratio is -4.52.

shares fell 2.02% to reach a new 52-week low of $29.10. PHI shares have dropped 29.70% over the past 52 weeks, while the S&P 500 index has gained 9.05% in the same period.